American Business Times
SEE OTHER BRANDS

The best business and economy news from the United States

American Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.

Press releases published on May 8, 2025

Tejon Ranch Co. Announces First Quarter 2025 Financial Results

Tejon Ranch Co. Announces First Quarter 2025 Financial Results

TEJON RANCH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three-months ended March 31, 2025. “Tejon Ranch is …

AMN Healthcare Announces First Quarter 2025 Results

AMN Healthcare Announces First Quarter 2025 Results

Quarterly revenue of $690 million;  GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations …

HCI Group Reports First Quarter 2025 Results

HCI Group Reports First Quarter 2025 Results

First Quarter Diluted EPS of $5.35 First Quarter Pre-Tax Income of $100.3 million Exzeo Ready to be Standalone Company TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE:HCI) reported pre-tax income of $100.3 million and net income of $74. …

DraftKings Reports First Quarter Revenue of $1,409 Million

DraftKings Reports First Quarter Revenue of $1,409 Million

BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced its first quarter 2025 financial results. The Company also posted a letter to shareholders and an earnings presentation on the Investor …

Abacus Global Management Reports First Quarter 2025 Results

Abacus Global Management Reports First Quarter 2025 Results

– First Quarter 2025 Total Revenue More Than Doubled Year-over-Year to $44.1 Million – - Longevity Funds Attracted $122.8 Million in Capital Inflows - – GAAP Net Income of $4.6 Million – – Adjusted Net Income Grew 158% Year-over-Year to $17.3 Million – –  …

Turtle Beach Corporation Announces Growth in Revenue, Adjusted EBITDA and Gross Margins in First Quarter 2025 Results and $75 Million Share Repurchase Program

Turtle Beach Corporation Announces Growth in Revenue, Adjusted EBITDA and Gross Margins in First Quarter 2025 Results and $75 Million Share Repurchase Program

–Net Revenue of $63.9 million, up 14% compared to prior year– –Gross Margin improved to 36.6%, an increase of approximately 470 basis points compared to prior year– –Net Loss of $(0.7) million compared to Net Income of $0.2 million in prior year– –Adjusted …

Microchip Technology Announces Financial Results For Fourth Quarter and Fiscal Year 2025

Microchip Technology Announces Financial Results For Fourth Quarter and Fiscal Year 2025

For the quarter ended March 31, 2025 Net sales of $970.5 million, declined 5.4% sequentially and 26.8% from the year ago quarter.  The midpoint of our guidance provided on February 6, 2025 was net sales of $960.0 million. On a GAAP basis: gross profit of …

FTAI Infrastructure Inc. Reports First Quarter 2025 Results, Declares Dividend of $0.03 per Share of Common Stock

FTAI Infrastructure Inc. Reports First Quarter 2025 Results, Declares Dividend of $0.03 per Share of Common Stock

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FTAI Infrastructure”) today reported financial results for the first quarter 2025. The Company’s consolidated comparative financial statements and key …

Progyny, Inc. Announces First Quarter 2025 Results

Progyny, Inc. Announces First Quarter 2025 Results

Reports Record Revenue of $324.0 Million, Reflecting 16.5% Growth Raises Full Year Guidance Due to Strong Start to the Year Early Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE …

Monster Beverage Reports 2025 First Quarter Results

Monster Beverage Reports 2025 First Quarter Results

2025 First Quarter Highlights Gross Profit as a Percentage of Net Sales Improves to 56.5 Percent Operating Income Increases 5.1 Percent to $569.7 Million (7.9 Percent to $591.2 Million, Exclusive of the Alcohol Brands Segment, Non-GAAP) Net Income Per …

Investors in Anheuser-Busch InBev Risk Losing Dividend Yield Due to Unclaimed Belgian Tax Refunds

Investors in Anheuser-Busch InBev Risk Losing Dividend Yield Due to Unclaimed Belgian Tax Refunds

Anheuser-Busch InBev SA/NV (NYSE:BUD) LONDON, LONDON, UNITED KINGDOM, May 8, 2025 /⁨EINPresswire.com⁩/ -- Anheuser-Busch InBev SA/NV (Euronext: ABI, JSE:ANH; NYSE: BUD) has declared a final dividend of €1.00 per share for the 2024 financial year — a 22% …

ARKO Corp. Reports First Quarter 2025 Results

ARKO Corp. Reports First Quarter 2025 Results

RICHMOND, Va., May 08, 2025 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced financial results for the first quarter …

Allbirds Reports First Quarter 2025 Financial Results

Allbirds Reports First Quarter 2025 Financial Results

Delivers First Quarter Results in Line with and Above Guidance Ranges Reiterates Full Year 2025 Outlook and Provides Second Quarter 2025 Guidance SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that …

Leslie’s, Inc. Announces Second Quarter Fiscal 2025 Financial Results; Re-Affirms Full Year Guidance

Leslie’s, Inc. Announces Second Quarter Fiscal 2025 Financial Results; Re-Affirms Full Year Guidance

PHOENIX, May 08, 2025 (GLOBE NEWSWIRE) -- Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its …

PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program

PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 20% and was 40% of total revenue; CTV revenue grew over 50% year-over-year; and Supply Path Optimization represented a record 55%+ of total …

Oculis Reports Q1 2025 Financial Results and Provides Company Update

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R…

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

– Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for long-acting helicase-primase inhibitors ABI-5366 and ABI-1179 anticipated in fall 2025 – – New data from multiple programs highlighted …

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results

Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expected in Q3 2025, with topline data from both 4FRONT-1 and …

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date   CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service